Deleted ICD-10-PCS Code XW23346 Transfusion of Brexucabtagene Autoleucel Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technology Group 6
- Deleted — Not Valid for Claims
- Valid FY 2021
- Deleted in FY 2022
XW23346 is a deleted ICD-10-PCS code, removed from the code set effective October 1, 2021. It was valid for transfusion of Brexucabtagene Autoleucel Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technology Group 6 on inpatient discharges from October 1, 2020 through September 30, 2021, and later discharges must use a current code. The CMS conversion table maps it to XW033M7.
Replacement Codes for XW23346
The CMS ICD-10-PCS conversion table maps XW23346 to this code. Confirm the choice against the procedure documentation and the code page's table.
- XW033M7 Introduction of Brexucabtagene Autoleucel Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technology Group 7
Code History
Questions About XW23346
Is XW23346 still a valid ICD-10-PCS code?
No. XW23346 was deleted from ICD-10-PCS effective October 1, 2021, with the FY 2022 code set. It cannot be reported for inpatient discharges on or after that date.
What replaced XW23346?
The CMS ICD-10-PCS conversion table maps XW23346 to XW033M7. Confirm it matches the procedure documentation before you use it; a conversion is a starting point, not an automatic substitution.
Can I still use XW23346 for older discharges?
Yes, for inpatient discharges from October 1, 2020 through September 30, 2021. ICD-10-PCS codes are assigned by the code set in effect on the date of discharge, so a corrected or late claim for a discharge in that window still uses XW23346.
